Skip to main content
SpringerLink
Log in
Book cover

Secondary Hypertension pp 749–778Cite as

Drug-Induced and Exogenous Hypertension

  • Chapter
  • First Online:

  • 795 Accesses

Abstract

Numerous substances including prescription medications, over-the-counter medications, herbals, and other substances have been reported to be associated with the development of hypertension. The commonly used drugs such as nonsteroidal anti-inflammatory drugs or glucocorticoids may bring about sufficient elevation in blood pressure (BP) to raise the suspicion of secondary hypertension and can interfere with BP-lowering effects of antihypertensive agents in treated hypertensive patients and worsening BP control in known hypertensive patients. In clinical assessment of hypertension, careful collection of drug and food substance history is important when a diagnosis for secondary hypertension is considered, with close attention paid to not only prescription medications but also over-the-counter substances, illicit drugs, herbal products, and food substances, which may also affect BP, changes in BP that occur because of drugs, and other agents resulted from drug–drug or drug–food interactions. When feasible, drugs or food substances associated with increased BP should be reduced or discontinued, and alternative agents should be used [1, 2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.

    Article  PubMed  Google Scholar 

  2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–e115.

    CAS  PubMed  Google Scholar 

  3. Cushman WC, Cutler JA, Hanna E, et al. Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med. 1998;158:1197–207.

    Article  CAS  PubMed  Google Scholar 

  4. Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardio-vascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–81.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Masi S, Uliana M, Gesi M, et al. Drug-induced hypertension: know the problem to know how to deal with it. Vascul Pharmacol. 2019;115:84–8.

    Article  CAS  PubMed  Google Scholar 

  7. Guessous I, Eap CB. Blood pressure in relation to coffee and caffeine consumption. Curr Hypertens Rep. 2014;16:468.

    Article  PubMed  Google Scholar 

  8. Liu H, Yao J, Wang W, Zhang D. Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis. J Clin Hypertens. 2017;19:1032–41.

    Article  CAS  Google Scholar 

  9. Mosca L, Benjamin DJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243–62.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Issa Z, Seely EW, Rahme M. Effects of hormone therapy on blood pressure. Menopause. 2015;22:456–68.

    Article  PubMed  Google Scholar 

  11. Grossman A, Messerli FH. Drug induced hypertension-an unappreciated cause of secondary hypertension. Eur J Pharmacol. 2015;763:15–22.

    Article  CAS  PubMed  Google Scholar 

  12. Johnson BA, Wells LT, Roache JD, et al. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies. Am J Hypertens. 2005;18:813–22.

    Article  CAS  PubMed  Google Scholar 

  13. Penninkilampi R, Eslick EM, Eslick GD. The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis. J Hum Hypertens. 2017;31:699–707.

    Article  CAS  PubMed  Google Scholar 

  14. Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. Arch Intern Med. 2005;165:1686–94.

    Article  CAS  PubMed  Google Scholar 

  15. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry. 1998;59:502–8.

    Google Scholar 

  16. White WB. Cardiovascular effects of the cyclooxygenase inhibitors. Hypertension. 2007;49:408–18.

    Article  CAS  PubMed  Google Scholar 

  17. Kassel LE, Odum LE. Our own worst enemy: pharmacologic mechanisms of hypertension. Adv Chronic Kidney Dis. 2015;22:245–52.

    Article  PubMed  Google Scholar 

  18. Jain M. Chemotherapy agents and hypertension: a focus on angiogenesis blockade. Curr Hypertens Rep. 2007;9:320–8.

    Article  CAS  PubMed  Google Scholar 

  19. Abi Aad S, Pierce M, Barmaimon G, et al. Hypertension induced by chemotherapeutic and immunosuppresive agents: a new challenge. Crit Rev Oncol Hematol. 2015;93:28–35.

    Article  PubMed  Google Scholar 

  20. Maitland ML, Bakris GL, Black HR, et al. Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors. J Natl Cancer Inst. 2010;102:596–604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Milan A, Puglisi E, Ferrari L, et al. Arterial hypertension and cancer. Int J Cancer. 2014;134:2269–77.

    Article  CAS  PubMed  Google Scholar 

  22. M Mohsen Ibrahim, Albertino Damasceno. Hypertension in developing countries, Vol. 380. 11 Aug 2012. www.thelancet.com.

    Article  Google Scholar 

  23. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–248.

    Google Scholar 

  24. Robert M, Carey MD, Paul Muntner PHD, Hayden B, Bosworth PHD, Whelton PK. Prevention and control of hypertension JACC health promotion series. JACC. 2018;72(11):1278–93.

    Article  Google Scholar 

  25. Taal MW, Chertow GM, Marsden PA, Skorecki K, ASL Y, Brenner BM, et al. Brenner and Rector’s the kidney. Philadelphia: Saunders Elsevier; 2011.

    Google Scholar 

  26. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva: WHO; 2007.

    Google Scholar 

  27. Mente A, O’Donnell MJ, Rangarajan S, et al., for the PURE Investigators. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371:601–11.

    Google Scholar 

  28. Jackson SL, Cogswell ME, Zhao L, et al. Association between urinary sodium and potassium excretion and blood pressure among adults in the United States: National Health and Nutrition Examination Survey, 2014. Circulation. 2018;137:237–46.

    Article  CAS  PubMed  Google Scholar 

  29. Takase H, Sugiura T, Kimura G, Ohte N, Dohi Y. Dietary sodium consumption predicts future blood pressure and incident hypertension in the Japanese normotensive general population. J Am Heart Assoc. 2015;4:e001959.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens. 2006;24:215–33.

    Article  CAS  PubMed  Google Scholar 

  31. The Importance of Population-Wide Sodium Reduction as a Means to Prevent Cardiovascular Disease and Stroke. A call to action from the American Heart Association. Circulation. 2011;123:1138–43.

    Article  Google Scholar 

  32. Appel LJ, Frohlich ED, Hall JE, et al. Salt sensitivity of blood pressure. a scientific statement from the American Heart Association. Hypertension. 2016;68:e7–46.

    PubMed  Google Scholar 

  33. DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014;10:364–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Jayedi A, Rashidy-Pour A, Khorshidi M, ShabBidar S. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose-response meta-analysis of more than 2.3 million participants. Obes Rev. 2018;19:654–67.

    Article  CAS  PubMed  Google Scholar 

  35. Droyvold WB, Midthjell K, Nilsen TI, Holmen J. Change in body mass index and its impact on blood pressure: a prospective population study. Int J Obes (Lond). 2005;29:650–5.

    Article  CAS  Google Scholar 

  36. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991–1006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Young DB. Role of potassium in preventive cardiovascular medicine. Dordrecht: Kluwer Academic; 2001.

    Book  Google Scholar 

  38. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297:319–28.

    Article  Google Scholar 

  39. World Health Organization. Diet, nutrition and the prevention of chronic disease: report of a Joint WHO/FAO Expert Consultation. Geneva: WHO; 2003.

    Google Scholar 

  40. Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378. https://doi.org/10.1136/bmj.f1378.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Iimura O, Kijima T, Kikuchi K, Miyama A, Ando T, Nakao T, et al. Studies on the hypotensive effect of high potassium intake in patients with essential hypertension. Clin Sci. 1981;61:77–80S.

    Article  Google Scholar 

  42. Lesniak KT, Dubbert PM. Exercise and hypertension. Curr Opin Cardiol. 2001;16:356–9.

    Article  CAS  PubMed  Google Scholar 

  43. Hayashi T, Tsumura K, Suematsu C, et al. Walking to work and the risk for hypertension in men: the Osaka Health Survey. Ann Intern Med. 1999;131:21–6.

    Article  CAS  PubMed  Google Scholar 

  44. Carnethon MR, Gidding SS, Nehgme R, et al. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA. 2003;290:3092–100.

    Article  CAS  PubMed  Google Scholar 

  45. Liu J, Sui X, Lavie CJ, et al. Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men. J Am Coll Cardiol. 2014;64:1245–53.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Dimeo F, Pagonas N, Seibert F, Arndt R, Zidek W, Westhoff TH. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension. 2012;60:653–8.

    Article  CAS  PubMed  Google Scholar 

  47. Lian C. L’alcoholisme cause d’hypertension arterielle. Bull Acad Med (Paris). 1915;74:525–8.

    Google Scholar 

  48. Klatsky AL. Alcohol and cardiovascular mortality: common sense and scientific truth. J Am Coll Cardiol. 2010;55:1336–8.

    Article  PubMed  Google Scholar 

  49. 2017ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2017. https://doi.org/10.1016/j.jacc.2017.11.006.

    Article  PubMed  Google Scholar 

  50. Cushman WC, PATHS Group. Prevention and treatment of hypertension study (PATHS): alcohol reduction for hypertension and upper normal blood pressure. Am J Hypertens. 1995;8(4 Pt 2):27A.

    Article  Google Scholar 

  51. Groppelli A, Giorgi DM, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens. 1992;10:495–9.

    Article  CAS  PubMed  Google Scholar 

  52. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension. 2001;37:187–93.

    Article  CAS  PubMed  Google Scholar 

  53. xi Z, yongjian Y. The relationship between cold and the pathogenesis of essential hypertension. Southwest Mil Surg. 2014;16(2):171–2.

    Google Scholar 

  54. Ponjoan A, García-Gil MM, Martí R, et al. Derivation and validation of BOREAS, a risk score identifying candidates to develop cold-induced hypertension. Environ Res. 2014;132:190–6.

    Article  CAS  PubMed  Google Scholar 

  55. Sinha P, Taneja DK, Singh NP, et al. Seasonal variation in prevalence of hypertension: Implications for interpretation. Indian J Public Health. 2010;54(1):7.

    Article  PubMed  Google Scholar 

  56. Andrea Corsonello MD. Seasonal hypertension: a clue to explain the high prevalence of unrecognized hypertension in the elderly? Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA)[J]. Aging Clin Exp Res. 2003;15(4):296–300.

    Article  PubMed  Google Scholar 

  57. Brook RD. The environment and blood pressure. Cardiol Clin. 2017;35(2):213–21.

    Article  PubMed  Google Scholar 

  58. Kaushik S, Kaur J. Chronic cold exposure affects the antioxidant defense system in various rat tissues. Clin Chim Acta. 2003;333(1):69–77.

    Article  CAS  PubMed  Google Scholar 

  59. Zucker IH. Brain angiotensin II: new insights into its role in sympathetic regulation. Circ Res. 2002;90(5):503–5.

    Article  CAS  PubMed  Google Scholar 

  60. Sun Z, Cade R, Zhang Z, et al. Angiotensinogen gene knockout delays and attenuates cold-induced hypertension. Hypertension. 2003;41(2):322–7.

    Article  CAS  PubMed  Google Scholar 

  61. Sun Z, Cade R, Morales C. Role of central angiotensin II receptors in cold-induced hypertension. Am J Hypertens. 2002;15(1):85–92.

    Article  CAS  PubMed  Google Scholar 

  62. Zhu Z, Zhu S, Zhu J, et al. Endothelial dysfunction in cold-induced hypertensive rats. Am J Hypertens. 2002;15(2):176–80.

    Article  CAS  PubMed  Google Scholar 

  63. Xiong S, Wang B, Lin S, et al. Activation of transient receptor potential melastatin subtype 8 attenuates cold-induced hypertension through ameliorating vascular mitochondrial dysfunction. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2017;6(8):e005495.

    Google Scholar 

  64. Ruifang L, Jianya S, Ping Z, et al. Analysis of hypertension and its influencing factors in workers exposed to high temperature. China Public Health. 2009;25(7):818–20.

    Google Scholar 

  65. Yue-Lin Y, Ren-Yi W, Zhu-Bao C, et al. Study of the Hamilton depression scale as a monitoring and diagnostic indicator of the influence of high temperature on human body. Occup Health Dis Injury. 1998;(2):71–3.

    Google Scholar 

  66. Iftach S, Alina V, Victor N, et al. The combined effect of high ambient temperature and antihypertensive treatment on renal function in hospitalized elderly patients. PLoS One. 2016;11(12):e0168504.

    Article  CAS  Google Scholar 

  67. Current status and influencing factors of hypertension in occupational population in some provinces of China. Chin J Circul. 2014,29(3):172–5.

    Google Scholar 

  68. Glenn BS, Bandeen-Roche K, Lee BK, et al. Changes in systolic blood pressure associated with lead in blood and bone. Epidemiology. 2006;17(5):538–44.

    Article  PubMed  Google Scholar 

  69. Zhang A, Hu H, Sánchez BN, et al. Association between prenatal lead exposure and blood pressure in children. Environ Health Perspect. 2011;120(3):445–50.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Rehkopf DH, Modrek S, Cantley LF, et al. Social, psychological, and physical aspects of the work environment could contribute to hypertension prevalence. Health Aff. 2017;36(2):258.

    Article  Google Scholar 

  71. Dzhambov AM, Dimitrova DD. Residential road traffic noise as a risk factor for hypertension in adults: systematic review and meta-analysis of analytic studies published in the period 2011–2017. Environ Pollut. 2018;240:306–18.

    Article  CAS  PubMed  Google Scholar 

  72. Ruifang L, Jianya S, Ping Z, et al. Analysis of hypertension and its influencing factors in high temperature workers. China Public Health. 2009;25(7):818–20.

    Google Scholar 

  73. Vogelaere P, Deklunder G, Lecroart J, et al. Factors enhancing cardiac output in resting subjects during cold exposure in air environment. J Sports Med Phys Fit. 1992;32(4):378.

    CAS  Google Scholar 

  74. Lijuan C, Zhizhong K, Jianguo C, et al. Discussion on the effect of microwave radiation on the health of workers. Chin J Radiat Health. 2006;15(3):321.

    Google Scholar 

  75. Li R, Gao X, Liu B, et al. Prospective cohort study to elucidate the correlation between occupational stress and hypertension risk in oil workers from Kelamayi City in the Xinjiang Uygur autonomous region of China. Int J Environ Res Public Health. 2017;14(1):1.

    Article  Google Scholar 

  76. Tessiersherman B, Galusha D, Cantley LF, et al. Occupational noise exposure and risk of hypertension in an industrial workforce. Am J Ind Med. 2017;60(12):1031.

    Article  Google Scholar 

  77. Martínez-González MA, Bes-Rastrollo M, et al. Alcohol consumption and the incidence of hypertension in a Mediterranean Cohort: The SUN Study. Rev Esp Cardiol. 2009;62(6):633–41.

    Article  PubMed  Google Scholar 

  78. Xianyan J, Xiangfeng D, Ying Y, et al. Study on the correlation between alcohol consumption and blood pressure. Prev Control Chronic Dis China. 2006;14(2):91–3.

    Google Scholar 

  79. Fan JG, Zhu J, Li XX, et al. Epidemiological investigation on the relationship between alcohol consumption and metabolic syndrome in adults in Shanghai. Liver. 2005;10(1):11–5. (in Chinese with English abstract.

    Google Scholar 

  80. Yunxia L, Cai J-Y. Alcohol consumption and cardiovascular diseases. Prog Cardiovasc Dis. 2008;29(3):462–5.

    Google Scholar 

  81. Ronksley PE, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Xiang Z, Jun L, Saihua W, et al. Effects of alcohol consumption on circadian rhythm of blood pressure in male hypertensive patients. Chin J Hypertens. 2010;18(9):880–4.

    Google Scholar 

  83. Benjamin T, Irving HM. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981–90.

    Article  Google Scholar 

  84. Chen WY, Rosner B. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011;306(17):1884–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med. 1995;332:1245.

    Article  CAS  PubMed  Google Scholar 

  86. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337:1705.

    Article  CAS  PubMed  Google Scholar 

  87. Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study. BMJ. 1996;312:736.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Dai J, Mukamal KJ, Krasnow RE, et al. Higher usual alcohol consumption was associated with a lower 41-y mortality risk from coronary artery disease in men independent of genetic and common environmental factors: the prospective NHLBI Twin Study. Am J Clin Nutr. 2015;102:31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Muntwyler J, Hennekens CH, Buring JE, Gaziano JM. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet. 1998;352:1882.

    Article  CAS  PubMed  Google Scholar 

  90. Mukamal KJ, Chen CM, Rao SR, Breslow RA. Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. J Am Coll Cardiol. 2010;55:1328.

    Article  PubMed  Google Scholar 

  91. Di Castelnuovo A, Costanzo S, Bagnardi V, et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437.

    Article  PubMed  Google Scholar 

  92. Wannamethee G, Shaper AG. Alcohol and sudden cardiac death. Br Heart J. 1992;68:443.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Camargo CA Jr, Stampfer MJ, Glynn RJ, et al. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med. 1997;126:372.

    Article  PubMed  Google Scholar 

  94. McElduff P, Dobson AJ. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ. 1997;314:1159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Reynolds K, Lewis B, Nolen JD, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579.

    Article  PubMed  Google Scholar 

  96. Mukamal KJ, Ascherio A, Mittleman MA, et al. Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage. Ann Intern Med. 2005;142:11.

    Article  PubMed  Google Scholar 

  97. Sacco RL, Elkind M, Boden-Albala B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA. 1999;281:53.

    Article  CAS  PubMed  Google Scholar 

  98. Elkind MS, Sciacca R, Boden-Albala B, et al. Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke. 2006;37:13.

    Article  PubMed  Google Scholar 

  99. Rehm JT, Bondy SJ, Sempos CT, Vuong CV. Alcohol consumption and coronary heart disease morbidity and mortality. Am J Epidemiol. 1997;146:495.

    Article  CAS  PubMed  Google Scholar 

  100. Hvidtfeldt UA, Tolstrup JS, Jakobsen MU, et al. Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation. 2010;121:1589.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol. Intern Emerg Med. 2019;14(1):143–60.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Center of Hypertension of People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China

    Nanfang Li, Mulalibieke Heizhati, Shan Lu & Niluofeier Aierken

Authors
  1. Nanfang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mulalibieke Heizhati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shan Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Niluofeier Aierken
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Center of Hypertension of People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China

    Nanfang Li

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Li, N., Heizhati, M., Lu, S., Aierken, N. (2020). Drug-Induced and Exogenous Hypertension. In: Li, N. (eds) Secondary Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-15-0591-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0591-1_20

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0590-4

  • Online ISBN: 978-981-15-0591-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation